After living with a myasthenia gravis diagnosis for almost six years, my experience with the disease has been characterized by being in “the middle.” I first experienced symptoms of double vision, in which my view of the world was duplicated—sometimes side by side, sometimes stacked, sometimes at an angle. For instance, to pour milk into my cereal bowl without spilling, I realized that I had to estimate the depth and perception somewhere in the center of the two pictures.

As I sought answers to these new symptoms, living in middle-of-nowhere rural Kentucky was an obstacle to accessing a specialist with the knowledge to properly diagnose this rare disease. However, unlike many of my neighbors, I was lucky to have resources and support that enabled me to travel for care and receive a definitive diagnosis in under a year—a luxury of time that many others in the rare disease community do not have. Despite the luck of a shorter diagnostic odyssey and fast access to treatment options, the toll of new symptoms, treatment burden, and surgery recovery during a global pandemic forced me into a mid-career pivot. I had to face my changed abilities and meet myself in the middle of where I thought I would be headed in life and where the disease was taking me.

As I reckoned with a new trajectory, the #RAREis Scholarship enabled and empowered me to return to school to earn a Graduate Certificate in Nonprofit Management, emerging with 12 credit hours toward a master’s degree. Learning about strategic planning, grant writing, and nonprofit management attached valuable credentials to over a decade of volunteer leadership and service to nonprofits. Next, I began pursuing a Graduate Certificate in Population Health, combining credits toward a Master of Public Health and gaining a broader understanding of public health systems and healthcare policy concepts. While I continue carving my path in this program, I have become an employee of the Myasthenia Gravis Foundation of America (MGFA), a patient advocacy organization with a shared vision of A World Without MG. At MGFA, I serve as a conduit of the patient voice in research and advocacy endeavors, working behind the scenes—between patients, researchers, and clinicians—to infuse the patient perspective into all aspects of research and therapeutic development.

I encourage every rare disease patient to practice telling their story and being honest about their needs. For advocacy on Capitol Hill during Rare Disease Week, that comes in the form of a 1-2 minute “pitch” or “elevator speech” in which you explain the disease, share your story and how it has affected your life, and make an “ask” or request for what can be done to help in terms of policy.

In everyday life, advocacy can be as simple as explaining MG, telling someone why you use a cane or wear an eyepatch, saying no to taking on a commitment, or requesting information from your doctor about a new treatment. Your “ask” could be for a relative to check out the MGFA website to learn more about your disease or for a boss to help find solutions for mitigating activities that cause you fatigue.

Increasing awareness of MG, telling your story, and articulating your needs is advocacy in a nutshell—and advocacy is the best way to get unstuck from the middle of where we are and where we want to be.